Tf ligand-receptor-mediated exenatide-Zn2+ complex oral-delivery system for penetration enhancement of exenatide
Autor: | Youxin Li, Yina Song, Kaoxiang Sun, Yanan Shi, Xuemei Zhang, Liping Zhang, Dongyu Duan |
---|---|
Rok vydání: | 2018 |
Předmět: |
inorganic chemicals
0301 basic medicine chemistry.chemical_classification Chemistry technology industry and agriculture Pharmaceutical Science 02 engineering and technology Pharmacology 021001 nanoscience & nanotechnology In vitro Bioavailability 03 medical and health sciences Subcutaneous injection 030104 developmental biology Pharmacokinetics In vivo Oral administration Transferrin medicine 0210 nano-technology Exenatide medicine.drug |
Zdroj: | Journal of Drug Targeting. 26:931-940 |
ISSN: | 1029-2330 1061-186X |
Popis: | Safe and effective oral delivery of peptide is a challenge. Here, we used exenatide and zinc ions (Zn2+) to form a complex to explore a meaningful oral-targeted drug-delivery system. Polyethylene glycol-poly(lactic acid-co-glycolic acid) (PEG-PLGA) was used to prepare nanoparticles (NPs) to escape the degradation caused by gastrointestinal enzymes. Transferrin (Tf) was used as a targeting group. PEG-PLGA-NPs and Tf-modified exenatide-Zn2+-loaded NPs (Tf-PEG-PLGA-NPs) were uniformly sized spheres according to transmission electron microscopy. The results of pharmacodynamic and pharmacokinetic investigations in vivo were consistent with in vitro studies using Caco-2 cells. Tf enhanced NPs transport in cell-uptake and transmembrane-transport experiments. Our results showed that the relative bioavailability of Tf-exenatide-Zn2+-NPs was higher than that of exenatide-Zn2+-NPs. The relative bioavailability of Tf-exenatide-Zn2+-NPs versus subcutaneous injection of exenatide was 6.45%. This was a preliminary exploration of the oral administration of exenatide, that data from which can be used for future investigations. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |